Cellectar Biosciences (CLRB) Q3 2026 Earnings

13AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-3.72
-2.65
-1.59
-0.52

Details

Expected EPS
-0.52
Actual EPS
-0.57
Surprise EPS
-0.05
Surprise Percent
+9.62%

Description

Cellectar Biosciences (CLRB) has reported earnings of -0.57 per share for Q3 2026.

0 Comments

Share your thoughts